Meta Information
ID:medicinal-mushrooms-beta-glucans
Name:Medicinal Mushrooms (Beta-Glucans)
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-07-02T07:04:56Z
Model
phase-b-newfiles-claude-opus-4.8
Interactions
Target id:
/class/immunosuppressants
Target name:
Immunosuppressants
Severity:
moderate
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Beta-glucans activate immune pathways and could oppose immunosuppressive therapy.
Actionable advice:
This is best avoided with immunosuppressants unless a specialist approves.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Beta-glucans are immune activators; theoretically antagonize immunosuppression. Mechanistic.
Label source:
Class inference
Action type:
avoid
Target id:
/class/antidiabetic-medications
Target name:
Antidiabetic medications
Severity:
minor
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Some mushroom beta-glucans modestly lower blood glucose.
Actionable advice:
It is a good idea to check glucose if combining.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mild glucose-lowering activity; low-certainty.
Label source:
Class inference
Action type:
monitor